Price and market overview of Laos version of obeticholic acid tablets

In recent years, the Lao version of Obeticholic acid generics has appeared in overseas markets. Its main ingredients are highly similar to the original Obeticholic acid, but there are obvious differences in selling price and packaging specifications. Laos ASEAN Pharmaceuticals is one of the well-known manufacturers. The product specifications they launch include 5mg*30 tablets and 10mg-30 tablets. Each box is priced between a few hundred to one thousand yuan. The specific price will also be affected by exchange rate fluctuations. In comparison, the price of the original obeticholic acid drug on the overseas market is as high as more than 9,000 US dollars per box, which is particularly expensive.

Obeeticholic acid, as a farnesoidX receptor (FXR) agonist, is an important bile acid regulating drug in the treatment of adult primary cholangitis (PBC). This drug is particularly useful in patients who have no evidence of cirrhosis or who have compensated cirrhosis but no evidence of portal hypertension. In the United States, it has been designated an orphan drug to treat this condition. For patients who are ineffective or intolerant to ursodeoxycholic acid treatment, obeticholic acid can be an effective alternative or combined treatment option.

However, it is worth noting that the approval of obeticholic acid is based on the reduction of alkaline phosphatase concentration, and its improvement in clinical symptoms and survival rate of patients has not been fully proven. Obeeticholic acid is an effective alternative treatment option for adult patients who are intolerant toUDCA or who have had an inadequate response to treatment with appropriate doses of UDCA for at least one year. The recommended starting dose is 5 mg once daily, taken with or without food. If a patient's alkaline phosphatase or total bilirubin levels have not decreased significantly after three months of obeticholic acid treatment, an increase in dose to 10 mg once daily may be considered.